|
![]() |
|||
|
||||
OverviewThis text describes the development of the Epstein-Barr virus vaccine, which may ultimately eliminate or reduce the incidence of the cancers associated with this virus in humans. These include nasopharyngial carcinoma, endemic Burkitts lymphoma and certain lymphomas which occur with a relatively high frequency in immunosuppressed patients and AIDS sufferers. Such vaccines may also be deployed in the prevention of infectious mononucleosis. Several candidate vaccines based on recombinant viral envelope glycoproteins and a range of viral vectors are evaluated in a primate animal model of lymphoma induced by the virus. Full Product DetailsAuthor: A. John MorganPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: illustrated edition Weight: 0.590kg ISBN: 9783540588863ISBN 10: 3540588868 Pages: 137 Publication Date: 01 April 1995 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |